Minor Histocompatibility Antigen-Specific T Cells

Corinne Summers(Seattle Children's Hospital), Marie Bleakley(Unknown)

Frontiers in Pediatrics

June 3, 2020

10.3389/fped.2020.00284

Cited by 32

Related Papers

CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia

|Journal of Clinical Investigation|2020|111

Neoantigens in Hematologic Malignancies

|Frontiers in Immunology|2020|42

HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation

|Blood|2024|29

Decreasing chronic graft-versus-host disease rates in all populations

|Blood Advances|2024|23

Phase I Study of Adoptive Immunotherapy with HA-1-Specific CD8+ and CD4+ Memory T Cells for Children and Adults with Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Trial in Progress

|Blood|2020|6